Theranos News

SEC Focus on Unicorn Start Ups Could Change Private Company D&O Insurance

Unicorn start-ups are facing increasing scrutiny by the U.S. Securities and Exchange Commission (SEC) for several reasons, including the potential for inflated valuations and misleading statements both of which pose a risk to investors, according to Kim Melvin, a partner …